Phase
Showing 1 - 25 of >10,000
Metabolic Alternation and Clinicohematological Characteristic in
Not yet recruiting
- CML, Chronic Phase
- Tyrosine kinase inhibitor
- (no location specified)
Nov 6, 2023
Obstructive Sleep Apnea Trial (IHL-42X Low Dose, IHL-42X High Dose, Placebo)
Not yet recruiting
- Obstructive Sleep Apnea
- IHL-42X Low Dose
- +5 more
- (no location specified)
Nov 22, 2023
Has a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or Lymphoma Trial in Shanghai (Phase I
Not yet recruiting
- Has a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or Lymphoma
- Phase I dose escalation
- +3 more
-
Shanghai, Shanghai, ChinaFudan Cancer Hospital
Apr 24, 2023
Locally Advanced Solid Tumors, Metastatic Solid Tumors Trial in Worldwide (Oral repotrectinib (TPX-0005))
Recruiting
- Locally Advanced Solid Tumors
- Metastatic Solid Tumors
- Oral repotrectinib (TPX-0005)
-
Yuma, Arizona
- +175 more
Jan 25, 2023
Acute Phase Reactant in Non-COVID-19 Bacterial Pneumonia
Completed
- Pneumonia
- Acute-Phase Reaction
- Blood sampling
-
Cairo, EgyptKasr alainy school of medicine
Jun 29, 2023
NSCLC Trial (Phase I - Mirdametinib - Level 1, Phase II - Mirdametinib, Phase I - Mirdametinib - Level 2)
Not yet recruiting
- Non-Small Cell Lung Cancer
- Phase I - Mirdametinib - Level 1
- +4 more
- (no location specified)
Jul 7, 2023
In Vitro Fertilization, ICSI Intracytoplasmic Spermatozoid Injection Trial in Bondy (Ovulation induction with hCG + Luteal phase
Not yet recruiting
- In Vitro Fertilization
- ICSI Intracytoplasmic Spermatozoid Injection
- Ovulation induction with hCG + Luteal phase support with vaginal progesterone
- Ovulation triggering by Triptorelin + Luteal phase support by Nafarelin
-
Bondy, FranceMaeliss Peigné
Nov 27, 2023
Prostate Cancer Trial in Beijing, Shanghai (Phase I:[177Lu]Lu-XT033 Injection, Phase II:[177Lu]Lu-XT033 Injection)
Not yet recruiting
- Prostate Cancer
- Phase I:[177Lu]Lu-XT033 Injection
- Phase II:[177Lu]Lu-XT033 Injection
-
Beijing, Beijing, China
- +1 more
Oct 7, 2023
Hip Fractures, Gait Disorders in Old Age Trial in Arganda Del Rey, Madrid (Preliminary Phase, Phase I - Early gait
Enrolling by invitation
- Hip Fractures
- Gait Disorders in Old Age
- Preliminary Phase
- +2 more
-
Arganda Del Rey, Madrid, Spain
- +1 more
Sep 1, 2023
Phenylketonuria Trial in Ankara (SAR444836)
Recruiting
- Phenylketonuria
-
Ankara, TurkeyInvestigational Site Number: 7920001
Aug 7, 2023
Duchenne Muscular Dystrophy Trial in Garches (Phase 1, SQY51, Phase 2a, SQY51 (cohort 1), Phase 2a, SQY51 (cohort 2))
Recruiting
- Duchenne Muscular Dystrophy
- Phase 1, SQY51
- +3 more
-
Garches, FranceHôpital Raymond Poincaré
Mar 7, 2023
Unilateral Spatial Neglect Trial (Prism 10 + visuo-motor activities, Neutral Prism + visuo-motor activities)
Not yet recruiting
- Unilateral Spatial Neglect
- Prism 10 + visuo-motor activities
- Neutral Prism + visuo-motor activities
- (no location specified)
Oct 5, 2023
Acute Gout Trial in Wuhan, Linyi, Shanghai (Recombinant Anti-IL-1ß Humanized Monoclonal Antibody Injection 100 mg (phase Ib),
Recruiting
- Acute Gout
- Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection 100 mg (phase Ib)
- +6 more
-
Wuhan, Hubei, China
- +2 more
Oct 17, 2022
HER2+ Advanced Breast Cancer, Other Solid Tumors Trial (ADCC-R-Epo-R T-cells + Trastuzumab, Erythropoietin beta, Fludarabine and
Not yet recruiting
- HER2+ Advanced Breast Cancer
- Other Solid Tumors
- ADCC-R-Epo-R T-cells + Trastuzumab
- +2 more
- (no location specified)
Aug 31, 2023
Cancer, Prostate Cancer, Metastatic Cancer Trial (177Lu-PSMA-I&T - escalating renal absorbed dose, 177Lu-PSMA-I&T - recommended
Not yet recruiting
- Cancer
- +3 more
- 177Lu-PSMA-I&T - escalating renal absorbed dose
- 177Lu-PSMA-I&T - recommended phase 2 regime
- (no location specified)
Jun 14, 2023
Health Behavior, Health Care Utilization Trial in Eugene (Phase II Promotores de Salud, Phase I Promotores de Salud Outreach)
Active, not recruiting
- Health Behavior
- Health Care Utilization
- Phase II Promotores de Salud
- Phase I Promotores de Salud Outreach
-
Eugene, OregonUniversity of Oregon
Jan 30, 2023
Neovascular Age-related Macular Degeneration Trial in Katy, Norfolk (SKG0106)
Not yet recruiting
- Neovascular Age-related Macular Degeneration
- SKG0106
-
Katy, Texas
- +1 more
Aug 15, 2023
Motor Neuron Disease Trial (EarSwitch device)
Not yet recruiting
- Motor Neuron Disease
- EarSwitch device
- (no location specified)
Oct 16, 2023
Mucopolysaccharidosis III-A Trial in Hamburg (JR-441)
Recruiting
- Mucopolysaccharidosis III-A
-
Hamburg, GermanyUniversitätsklinikum Hamburg-Eppendorf
Oct 18, 2023